Epiq Capital Group, LLC Applied Molecular Transport Inc. Transaction History

Epiq Capital Group, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$0.16 - $0.34 $830 - $1,764	-5,189 Reduced 0.06%	8,689,075 $1.39 Million
Q2 2023 Aug 11, 2023	SELL	$0.24 - $0.37 $6,523 - $10,057	-27,183 Reduced 0.31%	8,694,264 $2.26 Million
Q1 2023 May 11, 2023	SELL	$0.32 - $0.68 $15,274 - $32,459	-47,734 Reduced 0.54%	8,721,447 $2.79 Million
Q4 2022 Feb 13, 2023	SELL	$0.35 - $1.26 $105,140 - $378,505	-300,401 Reduced 3.31%	8,769,181 $3.68 Million
Q3 2022 Nov 09, 2022	BUY	$1.12 - $3.12 $6,536 - $18,208	5,836 Added 0.06%	9,069,582 $8.83 Million
Q2 2022 Aug 15, 2022	SELL	$2.76 - $7.65 $96,693 - $268,010	-35,034 Reduced 0.39%	9,063,746 $26.4 Million
Q1 2022 May 13, 2022	BUY	$5.63 - $13.88 $131,133 - $323,292	23,292 Added 0.26%	9,098,780 $68.4 Million
Q4 2021 Feb 09, 2022	BUY	$13.23 - $26.05 $878,908 - $1.73 Million	66,433 Added 0.74%	9,075,488 $127 Million
Q3 2021 Nov 12, 2021	BUY	$25.87 - $46.61 $6.32 Million - $11.4 Million	244,335 Added 2.79%	9,009,055 $233 Million
Q2 2021 Jul 30, 2021	BUY	$39.76 - $64.31 $2.66 Million - $4.3 Million	66,846 Added 0.77%	8,764,720 $401 Million
Q1 2021 May 03, 2021	BUY	$30.5 - $74.14 $1.05 Million - $2.55 Million	34,327 Added 0.4%	8,697,874 $383 Million
Q4 2020 Feb 01, 2021	BUY	$29.39 - $35.0 $2,380 - $2,835	81 Added 0.0%	8,663,547 $267 Million
Q3 2020 Nov 06, 2020	BUY	$20.49 - $33.58 $324,274 - $531,437	15,826 Added 0.18%	8,663,466 $276 Million
Q2 2020 Jul 27, 2020	BUY	$17.98 - $28.0 $155 Million - $242 Million	8,647,640 New	8,647,640 $217 Million

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Epiq Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Epiq Capital Group, LLC with notifications on news.